260 related articles for article (PubMed ID: 20027550)
1. Management of benign prostatic hypertrophy-related urinary retention: current trends and perspectives.
Stamatiou K
Urol J; 2009; 6(4):237-44. PubMed ID: 20027550
[TBL] [Abstract][Full Text] [Related]
2. Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.
Chapple C
Curr Opin Urol; 2010 Jan; 20(1):43-8. PubMed ID: 19875964
[TBL] [Abstract][Full Text] [Related]
3. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Antunes AA; Srougi M; Coelho RF; de Campos Freire G
Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
[TBL] [Abstract][Full Text] [Related]
6. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
Gerber GS; Jahoda A; Bales GT; Albala DM
Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
[TBL] [Abstract][Full Text] [Related]
7. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
Parsons JK
J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
[TBL] [Abstract][Full Text] [Related]
8. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
9. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
10. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
11. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
Alan McNeill S
Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
14. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
15. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
Yamaguchi O
Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
[TBL] [Abstract][Full Text] [Related]
16. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
17. Urinary retention and post-void residual urine in men: separating truth from tradition.
Kaplan SA; Wein AJ; Staskin DR; Roehrborn CG; Steers WD
J Urol; 2008 Jul; 180(1):47-54. PubMed ID: 18485378
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
19. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
Chapple CR; Roehrborn CG
Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
[TBL] [Abstract][Full Text] [Related]
20. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
